Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix, ParAllele Biosciences, Roche, Epigenomics, Applied DNA Sciences


Affy Supplies ParAllele with GeneChips

Affymetrix will supply ParAllele Biosciences with GeneChip microarrays to use in its SNP-genotyping technology, the companies said this week.

Under the three-year agreement, Affymetrix will provide ParAllele, of South San Francisco, Calif., with custom and catalog tag arrays to use with its commercial genotyping service business and in its collaborations with pharmaceutical companies. Parallele will also work to design SNP assays based on the Affy platform.

Roche, Epigenomics Pen Cancer DX Deal

Over the next three years, Roche will use DNA-methylation technologies developed by Epigenomics to develop molecular-diagnostic and pharmacogenomic assays for a variety of cancers.

Terms of the agreement, announced earlier this week, call for Roche to pay Epigenomics €4 million, or roughly $4.25 million. The deal also includes R&D funding, milestone payments, and royalties that could total €100 million, the partners said.

The products to be developed include diagnostic and prognostic tools for colon, breast, and prostate cancer, as well as pharmacogenomics tests that can predict a patient's response to cancer drugs.

Roche will use its PCR and microarray technology in the assays. The methylation technologies involve measuring the differences in DNA methylation between diseased and healthy conditions. Methylation, the phenomenon wherein a methyl group is attached to the cytosine base on DNA, is a major mechanism of control for gene expression.

Applied DNA Sciences Opens Office in NC

Applied DNA Sciences has opened an office in Henderson, NC. The new facility will allow the company to market its embedded-DNA authentication products to the textile, pharmaceutical, as well as homeland security agencies located on the east coast of the United States.

The company’s technology was devised to impact the more than $350 billion of counterfeit products sold annually around the world. The technology is being marketed via direct sales, channel partners, resellers, and certain undisclosed strategic alliances.

Applied DNA’s technology is designed to “mark” raw textile materials and finished goods. It can also identify both the country of origin as well as the specific factories where a garment and/or its components were produced.


Filed under

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.